Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-06-16

Clinical Trial Update: Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy [Phase 2]

View source ↗

Summary

Phase 2 trial of sunitinib malate in men with newly diagnosed prostate cancer prior to prostatectomy has completed and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sutent (sunitinib)

Snippet

Sponsor: Duke University | Conditions: Prostate Cancer, Prostatectomy | Phase 2 | Status: COMPLETED | Results posted: 2014-06-16